Table 5 Maximum acute toxicity during follow up and clinical parameters
From: Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
Characteristic | Grade > =2 Acute GI toxicity | P value | |
|---|---|---|---|
C-Arm (%) | H-Arm (%) | ||
ADT | 8 (7.6) | 13 (11.6) | 0.103 |
No ADT | 10 (9.5) | 10 (8.9) | |
PTV volume > =165 | 11 (10.4) | 11 (9.8) | 0.234 |
PTV volume < 165 | 7 (6.6) | 9 (8) | |
Rectal volume > = 60 | 9 (8.5) | 11 (9.8) | 0.545 |
Rectal volume < 60 | 9 (8.5) | 12 (10.7) | |
Age > = 70 | 11 (10.4) | 12 (10.7) | 0.756 |
Age < 70 | 8 (7.6) | 8 (7.1) | |
Grade > = 2 acute GU toxicity | |||
ADT | 10 (9.5) | 12 (10.7) | 0.645 |
No ADT | 12 (11.4) | 14 (12.5) | |
PTV volume > = 165 | 13 (12.3) | 15 (13.3) | 0.453 |
PTV volume < 165 | 9 (8.5) | 12 (10.7) | |
Bladder volume > = 260 | 9 (8.5) | 13 (11.6) | 0.987 |
Bladder volume < 260 | 13 (12.3) | 14 (12.5) | |
Age > =70 | 11 (10.4) | 14 (12.5) | 0.876 |
Age < 70 | 11 (10.4) | 13 (11.6) | |